chr3-39265934-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 2P and 13B. PM2BP4_StrongBP6_Very_StrongBP7
The NM_001337.4(CX3CR1):āc.576T>Cā(p.Asn192=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000169 in 1,614,090 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.00015 ( 0 hom., cov: 32)
Exomes š: 0.00017 ( 0 hom. )
Consequence
CX3CR1
NM_001337.4 synonymous
NM_001337.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.33
Genes affected
CX3CR1 (HGNC:2558): (C-X3-C motif chemokine receptor 1) Fractalkine is a transmembrane protein and chemokine involved in the adhesion and migration of leukocytes. The protein encoded by this gene is a receptor for fractalkine. The encoded protein also is a coreceptor for HIV-1, and some variations in this gene lead to increased susceptibility to HIV-1 infection and rapid progression to AIDS. Four transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.02).
BP6
Variant 3-39265934-A-G is Benign according to our data. Variant chr3-39265934-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 721354.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.33 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CX3CR1 | NM_001337.4 | c.576T>C | p.Asn192= | synonymous_variant | 2/2 | ENST00000399220.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CX3CR1 | ENST00000399220.3 | c.576T>C | p.Asn192= | synonymous_variant | 2/2 | 1 | NM_001337.4 | P1 | |
CX3CR1 | ENST00000358309.3 | c.672T>C | p.Asn224= | synonymous_variant | 2/2 | 2 | |||
CX3CR1 | ENST00000541347.5 | c.576T>C | p.Asn192= | synonymous_variant | 2/2 | 4 | P1 | ||
CX3CR1 | ENST00000542107.5 | c.576T>C | p.Asn192= | synonymous_variant | 2/2 | 4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152196Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
23
AN:
152196
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000188 AC: 47AN: 249544Hom.: 0 AF XY: 0.000214 AC XY: 29AN XY: 135384
GnomAD3 exomes
AF:
AC:
47
AN:
249544
Hom.:
AF XY:
AC XY:
29
AN XY:
135384
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000170 AC: 249AN: 1461894Hom.: 0 Cov.: 33 AF XY: 0.000190 AC XY: 138AN XY: 727248
GnomAD4 exome
AF:
AC:
249
AN:
1461894
Hom.:
Cov.:
33
AF XY:
AC XY:
138
AN XY:
727248
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000151 AC: 23AN: 152196Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74346
GnomAD4 genome
AF:
AC:
23
AN:
152196
Hom.:
Cov.:
32
AF XY:
AC XY:
10
AN XY:
74346
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 25, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at